In the present study, we performed immunohistochemical staining for E-cadherin and the nectin subtypes in 49 pancreatic adenocarcinomas to elucidate whether the expression of E-cadherin and nectins was correlated with the clinicopathological features and clinical outcomes of the patients. The gene discussed is NECTIN1; the disease is pancreatic adenocarcinoma.